Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Chlorphenoxamine |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Desmethylastemizole |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Clemizole |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Thenylpyramine |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Tripelennamine citrate |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Thenyldiamine |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Pyrathiazine (substance) |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Thonzylamine |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Piperidine derivative (substance) |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Olopatadine (substance) |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Ketotifen (substance) |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Thiethylperazine (substance) |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Phthalazinone derivative |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Histamine H1 receptor antagonist |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Propylamine derivative antihistamine |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Ethylenediamine derivative antihistamine |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Ikke-sederende antihistamin |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Sederende antihistamin |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Thonzylamine (substance) |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
ethanolaminoleat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
antihistamin til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
ethanolaminoleat 5 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Product containing trimethobenzamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Ethanolamine derivative histamine receptor antagonist product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Product containing histamine receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
1 |
Product containing piperazine derivative and histamine receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
ethanolaminoleat 50 mg/ml injektionsvæske, 2 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Product containing precisely trimethobenzamide hydrochloride 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Product containing precisely trimethobenzamide hydrochloride 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
trimethobenzamidhydrochlorid 100 mg/2 % suppositorium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
trimethobenzamidhydrochlorid 200 mg/2 % suppositorium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
trimethobenzamidhydrochlorid 100 mg/ml opløsning til intramuskulær anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
trimethobenzamidhydrochlorid 100 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
trimethobenzamidhydrochlorid 200 mg suppositorium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
trimethobenzamidhydrochlorid 100 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Trimethobenzamide hydrochloride 100mg/mL bar |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
benzocain 2% wt/wt + trimethobenzamidhydrochlorid 100 mg suppositorier |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
benzocain + trimethobenzamidhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
ethanolaminoleat 5 % injektionsvæske, opløsning, 2 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
ethanolaminoleat 5 % injektionsvæske, opløsning, 5 ml ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Poisoning by diphenylpyraline |
Causative agent |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Antihistamine poisoning (disorder) |
Causative agent |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
1 |
Product containing precisely trimethobenzamide hydrochloride 300 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
trimethobenzamidhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Product containing thiethylperazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
thiethylperazinmaleat 5 mg/ml injektionsvæske, opløsning, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Thiethylperazine malate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Product containing thiethylperazine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Product containing thiethylperazine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Product containing piperidine derivative (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
bivirkning af antihistamin til topikal anvendelse |
Causative agent |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
1 |
allergi over for antihistamin til topikal anvendelse |
Causative agent |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Adverse reaction to antihistamines |
Causative agent |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
1 |
Other antihistamine poisoning |
Causative agent |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Screening for antihistamine in urine (procedure) |
Component |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
2 |
Antihistamine measurement |
Component |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
1 |
allergi over for antihistamin til topikal anvendelse |
Causative agent |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
1 |
Niaprazine (substance) |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Histamine H2 receptor antagonist |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Antihistamine prophylaxis (procedure) |
Direct substance |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
2 |
Histamine H3 receptor antagonist |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Ranitidine bismuth citrate (substance) |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Pizotifen (substance) |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Dimenhydrinate (substance) |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Alimemazine |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Alimemazine tartrate |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Pizotifen maleate |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Piperazine derivative antihistamine |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Isothipendyl hydrochloride |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Azatadine maleate |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Piperidine derivative antihistamine |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Cyproheptadine hydrochloride (substance) |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Promethazine hydrochloride |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Promethazine teoclate |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Azatadine (substance) |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Oxatomide (substance) |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Mebhydrolin (substance) |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Phenindamine (substance) |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Doxylamine |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Chlorcyclizine |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Ethanolamine derivative antihistamine |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Cyclizine lactate |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Isothipendyl |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Cyclizine tartrate (substance) |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Buclizine (substance) |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Buclizine hydrochloride |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Promethazine (substance) |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Mequitazine (substance) |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Cyclizine hydrochloride (substance) |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Cyproheptadine (substance) |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Cyclizine (substance) |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Chloropyrilene |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Olopatadine hydrochloride |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Doxylamine succinate |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Phenindamine tartrate (substance) |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Captodiame |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Captodiame hydrochloride (substance) |
Is a |
True |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Esomeprazole sodium (substance) |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Esomeprazole magnesium trihydrate (substance) |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|
Esomeprazole (substance) |
Is a |
False |
Histamine receptor antagonist |
Inferred relationship |
Some |
|